• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主细胞中 Toll 样受体 3/7/9 的联合缺失导致 T 细胞依赖控制肿瘤生长。

Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth.

机构信息

Research Division of the Department of Otorhinolaryngology, University Hospital Essen, University Duisburg-Essen, Hufelandstrasse 55, D-45122 Essen, Germany.

Institute of Virology, University Hospital Essen, University Duisburg-Essen, D-45122 Essen, Germany.

出版信息

Nat Commun. 2017 Mar 16;8:14600. doi: 10.1038/ncomms14600.

DOI:10.1038/ncomms14600
PMID:28300057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5356072/
Abstract

Toll-like receptors (TLRs) are located either on the cell surface or intracellularly in endosomes and their activation normally contributes to the induction of protective immune responses. However, in cancer their activation by endogenous ligands can modulate tumour progression. It is currently unknown how endosomal TLRs regulate endogenous anti-tumour immunity. Here we show that TLR3, 7 and 9 deficiencies on host cells, after initial tumour growth, result in complete tumour regression and induction of anti-tumour immunity. Tumour regression requires the combined absence of all three receptors, is dependent on both CD4 and CD8 T cells and protects the mice from subsequent tumour challenge. While tumours in control mice are infiltrated by higher numbers of regulatory T cells, tumour regression in TLR-deficient mice is paralleled by altered vascular structure and strongly induced influx of cytotoxic and cytokine-producing effector T cells. Thus, endosomal TLRs may represent a molecular link between the inflamed tumour cell phenotype, anti-tumour immunity and the regulation of T-cell activation.

摘要

Toll 样受体 (TLRs) 位于细胞表面或细胞内的内体中,其激活通常有助于诱导保护性免疫反应。然而,在癌症中,内体 TLR 的激活可以调节肿瘤的进展。目前尚不清楚内体 TLR 如何调节内源性抗肿瘤免疫。在这里,我们表明,宿主细胞中 TLR3、7 和 9 的缺失,在初始肿瘤生长后,会导致完全的肿瘤消退和抗肿瘤免疫的诱导。肿瘤消退需要所有三种受体的联合缺失,依赖于 CD4 和 CD8 T 细胞,并保护小鼠免受随后的肿瘤挑战。虽然对照小鼠的肿瘤中浸润了更多数量的调节性 T 细胞,但 TLR 缺陷型小鼠的肿瘤消退伴随着血管结构的改变和细胞毒性和细胞因子产生的效应 T 细胞的强烈流入。因此,内体 TLR 可能是炎症肿瘤细胞表型、抗肿瘤免疫和 T 细胞激活调节之间的分子联系。

相似文献

1
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth.宿主细胞中 Toll 样受体 3/7/9 的联合缺失导致 T 细胞依赖控制肿瘤生长。
Nat Commun. 2017 Mar 16;8:14600. doi: 10.1038/ncomms14600.
2
Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.环磷酰胺与间隔性Toll样受体激动剂的重复循环对内源性抗肿瘤免疫的决定性激活。
Oncotarget. 2016 Jul 12;7(28):42919-42942. doi: 10.18632/oncotarget.10190.
3
Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.Toll样受体4介导由从寄生植物印度野菰中分离出的一种55千道尔顿蛋白质所诱导的抗肿瘤宿主反应。
Clin Diagn Lab Immunol. 2004 May;11(3):483-95. doi: 10.1128/CDLI.11.3.483-495.2004.
4
Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.在常见可变免疫缺陷中,Toll样受体激活后CD8(+) T细胞反应受损。
J Transl Med. 2016 May 17;14(1):138. doi: 10.1186/s12967-016-0900-2.
5
Control of B-cell responses by Toll-like receptors.Toll样受体对B细胞反应的调控
Nature. 2005 Nov 17;438(7066):364-8. doi: 10.1038/nature04267.
6
Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.PI3K 抑制剂和 Toll 样受体激动剂的免疫疗法诱导产生 IFN-γ+IL-17+多功能 T 细胞,介导小鼠肿瘤的排斥反应。
Cancer Res. 2012 Feb 1;72(3):581-91. doi: 10.1158/0008-5472.CAN-11-0307. Epub 2011 Dec 9.
7
Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo.浆细胞样树突状细胞对于体内炎症和 T 细胞免疫的启动至关重要。
Immunity. 2011 Dec 23;35(6):958-71. doi: 10.1016/j.immuni.2011.10.014. Epub 2011 Dec 15.
8
Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis.人扁桃体T细胞亚群中的Toll样受体:复发性扁桃体炎期间表达的改变
Respir Res. 2006 Feb 27;7(1):36. doi: 10.1186/1465-9921-7-36.
9
NK1.1+ cells are important for the development of protective immunity against MHC I-deficient, HPV16-associated tumours.NK1.1+ 细胞对于针对 MHC I 缺陷、HPV16 相关肿瘤的保护性免疫的发展很重要。
Oncol Rep. 2011 Jan;25(1):281-8.
10
Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.用源自分枝杆菌的 toll 样受体激动剂进行树突状细胞疫苗接种可增强抗肿瘤免疫力。
Oncotarget. 2015 Oct 20;6(32):33781-90. doi: 10.18632/oncotarget.5281.

引用本文的文献

1
Extracellular vesicles produced by avian pathogenic Escherichia coli (APEC) activate macrophage proinflammatory response and neutrophil extracellular trap (NET) formation through TLR4 signaling.禽致病性大肠杆菌(APEC)产生的细胞外囊泡通过 TLR4 信号通路激活巨噬细胞的促炎反应和中性粒细胞胞外诱捕网(NET)形成。
Microb Cell Fact. 2023 Sep 9;22(1):177. doi: 10.1186/s12934-023-02171-6.
2
Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients.不同的免疫和炎症反应模式有助于识别膀胱癌患者的不良预后和晚期临床特征。
Front Immunol. 2022 Oct 27;13:1008865. doi: 10.3389/fimmu.2022.1008865. eCollection 2022.
3

本文引用的文献

1
Microbiome and Anticancer Immunosurveillance.微生物组与抗肿瘤免疫监视
Cell. 2016 Apr 7;165(2):276-87. doi: 10.1016/j.cell.2016.03.001.
2
Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.癌症治疗性Toll样受体配体诱导的肿瘤细胞死亡的差异性免疫调节活性
Cancer Immunol Immunother. 2016 Jun;65(6):689-700. doi: 10.1007/s00262-016-1828-3. Epub 2016 Mar 31.
3
TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis.Toll样受体信号传导及促炎细胞因子作为肿瘤发生的驱动因素。
IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph Nodes.
IFNAR1 缺陷削弱肿瘤引流淋巴结中中性粒细胞的免疫刺激特性。
Front Immunol. 2022 Jun 27;13:878959. doi: 10.3389/fimmu.2022.878959. eCollection 2022.
4
Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy.结肠癌中RAGE/AGEs轴与炎症/免疫治疗之间的相互作用。
Oncotarget. 2021 Jun 22;12(13):1281-1295. doi: 10.18632/oncotarget.27990.
5
Signaling Through Nucleic Acid Sensors and Their Roles in Inflammatory Diseases.核酸传感器的信号转导及其在炎症性疾病中的作用。
Front Immunol. 2021 Jan 28;11:625833. doi: 10.3389/fimmu.2020.625833. eCollection 2020.
6
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives.癌症的脂质代谢图景与新的治疗前景
Front Oncol. 2020 Dec 8;10:605154. doi: 10.3389/fonc.2020.605154. eCollection 2020.
7
TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse Model.B 细胞 TLR9 缺陷通过白细胞介素-10 在 1 型糖尿病小鼠模型中促进免疫耐受。
Diabetes. 2021 Feb;70(2):504-515. doi: 10.2337/db20-0373. Epub 2020 Nov 5.
8
Autophagy, the innate immune response and cancer.自噬、先天免疫反应与癌症。
Mol Oncol. 2020 Sep;14(9):1913-1929. doi: 10.1002/1878-0261.12774. Epub 2020 Aug 30.
9
Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.肝癌细胞内 TLR9 的激活通过 PD-L1 的上调诱导肝癌的免疫逃逸。
Theranostics. 2020 May 17;10(14):6530-6543. doi: 10.7150/thno.44417. eCollection 2020.
10
Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma.肿瘤衍生肽聚糖识别蛋白 2 预测肝细胞癌的生存和抗肿瘤免疫反应。
Hepatology. 2020 May;71(5):1626-1642. doi: 10.1002/hep.30924. Epub 2020 Jan 24.
Cytokine. 2017 Jan;89:127-135. doi: 10.1016/j.cyto.2016.01.021. Epub 2016 Feb 4.
4
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.共生双歧杆菌可促进抗肿瘤免疫并增强抗程序性死亡受体配体1(PD-L1)的疗效。
Science. 2015 Nov 27;350(6264):1084-9. doi: 10.1126/science.aac4255. Epub 2015 Nov 5.
5
More than a scaffold: Stromal modulation of tumor immunity.不止是支架:基质对肿瘤免疫的调节作用
Biochim Biophys Acta. 2016 Jan;1865(1):3-13. doi: 10.1016/j.bbcan.2015.06.001. Epub 2015 Jun 10.
6
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy.诱导免疫原性肿瘤细胞死亡的物理治疗方式用于癌症免疫治疗。
Oncoimmunology. 2015 Jan 7;3(12):e968434. doi: 10.4161/21624011.2014.968434. eCollection 2014 Dec.
7
Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.Toll样受体7在口腔鳞状细胞癌肿瘤细胞和成纤维样细胞中的不同表达模式
Histopathology. 2015 Nov;67(5):730-9. doi: 10.1111/his.12703. Epub 2015 May 19.
8
S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.S100A9诱导的炎症反应在体外和体内由不同的损伤相关分子模式(DAMP)受体介导。
PLoS One. 2015 Feb 23;10(2):e0115828. doi: 10.1371/journal.pone.0115828. eCollection 2015.
9
Innate sensing of microbial products promotes wound-induced skin cancer.对微生物产物的先天感知会促进伤口诱导的皮肤癌。
Nat Commun. 2015 Jan 9;6:5932. doi: 10.1038/ncomms6932.
10
Complexity of danger: the diverse nature of damage-associated molecular patterns.危险的复杂性:损伤相关分子模式的多样性
J Biol Chem. 2014 Dec 19;289(51):35237-45. doi: 10.1074/jbc.R114.619304. Epub 2014 Nov 12.